CMR Substances and Why They Are Banned in EU Cosmetics
How carcinogenic, mutagenic, and reprotoxic classification triggers an automatic EU cosmetics ban, and the narrow derogation exception.
There's a category of prohibition in EU cosmetics law that doesn't work like most ingredient bans. Most restricted or banned substances get evaluated one at a time, an expert committee looks at the safety data, weighs exposure and use patterns, and issues a specific ruling. CMR substances skip that individual process almost entirely, because the classification itself does the work.
What CMR actually stands for
CMR is shorthand for Carcinogenic, Mutagenic, or toxic for Reproduction. These are substances already classified under the EU's broader chemical hazard classification system as capable of causing cancer, causing genetic mutations, or causing reproductive or developmental harm. The classification comes from chemical hazard law generally, not from a cosmetics-specific safety review.
Under Regulation (EC) No 1223/2009, once a substance carries a CMR classification, it's automatically prohibited from use in cosmetic products. The regulation doesn't ask "is this substance safe at the concentration cosmetics typically use it at." It says, in effect, this hazard classification is disqualifying on its own for this product category.
Why the automatic approach makes sense here
Cosmetics are used repeatedly, often daily, sometimes over a lifetime, and frequently on children or during pregnancy. A substance that's genotoxic or reproductively toxic carries a different risk calculus than one that's simply irritating or allergenic, where concentration limits and warning labels can meaningfully manage the risk. For CMR substances, the EU's position is that the hazard itself is disqualifying for a voluntary-use product category like cosmetics, rather than something to be managed through use limits.
This is also why formulators need to track chemical classification news generally, not just cosmetics-specific regulatory updates. A raw material can lose its status as usable in cosmetics because of a reclassification decision made in an entirely different regulatory context, one that has nothing to do with cosmetics on its face.
The derogation route, and why it's narrow
There is a path for a CMR-classified substance to remain usable in cosmetics, but it's a genuine exception, not a loophole most formulators will ever use. A derogation requires demonstrating, through a dedicated safety evaluation specific to cosmetic use, that the substance meets conditions set for that narrow exception, which typically involves showing there's no safe alternative and that exposure through cosmetic use specifically has been rigorously assessed.
This process runs through the EU's scientific committee structure and results in the substance being added to one of the regulation's annexes with specific conditions attached, rather than simply being cleared for general use. For a small or mid-size brand formulating with a newly classified CMR ingredient, waiting for or pursuing a derogation isn't a realistic timeline. The practical response is almost always reformulation.
What this means for your ingredient sourcing
| Situation | What to do |
|---|---|
| Supplier tells you an ingredient's CMR status has changed | Treat it seriously immediately, don't wait for your own literature review |
| You're formulating with a raw material you haven't used before | Check its current hazard classification, not just its cosmetic safety history |
| A long-used ingredient in your formula gets reclassified | Reformulate rather than wait on a derogation, unless a derogation is already in place |
| Your safety assessor flags a CMR concern | Take it as a hard stop on that version of the formula, not a note to negotiate around |
The role of your safety assessor here
Your Cosmetic Product Safety Report, signed by a qualified safety assessor, is exactly where this gets caught if it hasn't been already. A competent assessor checks every ingredient's current classification status as part of putting together the CPSR, not just its historical use in cosmetics. If your Product Information File and CPSR haven't been updated recently and your formula includes ingredients that were common a few years ago but have had classification news since, that's worth a fresh look before you rely on an old safety report.
Because CMR status changes independently of the cosmetics regulatory calendar, this is one area where a good ingredient screening process pays for itself. Cosmetic Comply's ingredient-to-INCI mapping and restricted-substance screening is designed to flag exactly this kind of prohibition automatically as part of preparing a filing, though its EU notification support is still being built out alongside the Canadian filing system that's live today.
The takeaway isn't complicated even if the underlying chemistry is: if an ingredient carries a CMR classification, assume it's off the table for a cosmetic formula unless you have specific, current confirmation of an active derogation covering your exact use.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Reporting Serious Undesirable Effects Through the CPNP
A customer complaint about a burning rash is not just feedback, it may be a serious undesirable effect you are obligated to report.
Minimum Durability Dates on EU Cosmetic Labels
How the EU hourglass symbol differs from PAO, and what stability data actually has to back up each one on your label.
Stating the Function on an EU Label When It Is Not Obvious
When EU Regulation 1223/2009 requires a stated product function on the label, with soap and serum examples showing where it applies.
Can You Sell a CBD Cosmetic in the EU CPNP
The CosIng entry situation for cannabidiol, and why THC content and narcotic status constrain whether a CBD cosmetic can be notified in the EU at all.